RNAi in humans: Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement Meeting Abstract
| Authors: | Vaishnaw, A. K.; Cervantes, A.; Alsina, M.; Tabernero, J.; Infante, J. R.; LoRusso, P.; Shapiro, G. I.; Paz-Ares, L.; Schwartz, G.; Weiss, G.; Falzone, R.; Hill, J.; Cehelsky, J.; White, A.; Toudjarska, I.; Bumcrot, D.; Meyers, R.; Hinkle, G.; Svrzikapa, N.; Sah, D. W.; Burris, H. A.; Gollob, J. A. |
| Abstract Title: | RNAi in humans: Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement |
| Meeting Title: | 7th Annual Meeting of the Oligonucleotide-Therapeutics-Society |
| Journal Title: | Nucleic Acid Therapeutics |
| Volume: | 21 |
| Issue: | 5 |
| Meeting Dates: | 2011 Sep 8-10 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 2159-3337 |
| Publisher: | Mary Ann Liebert, Inc |
| Date Published: | 2011-01-01 |
| Start Page: | A44 |
| Language: | English |
| ACCESSION: | WOS:000296231700096 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract - 7th Annual Meeting of the Oligonucleotide-Therapeutics-Society - SEP 08-10, 2011 - Copenhagen, DENMARK - "Source: Wos" |
MSK Authors
-
385Schwartz
Related MSK Work